Pulmonary hypertension is a common complication of systemic sclerosis and generally portends a very poor prognosis. Response to modern therapy for scleroderma-related pulmonary arterial ...

Substantial evidence exists that patients with scleroderma have immune dysfunction ... (23% versus <5%), and a higher proportion of pulmonary fibrosis in controls than in mycophenolate-mofetil ...

A treatment for fatal lung diseases such as idiopathic pulmonary fibrosis is being ... such as cardiac fibrosis and scleroderma. The company was co-founded in 2013 by Steven Idell and Andrew ...